Chris Brown

Executive Director at GSK

Speaker

Chris Brown currently serves as Executive Director, Business Development Transactions at GSK where he works on transactions to bring external innovation into the company and enhance the R&D pipeline with preclinical and clinical stage assets. With over 25 years of experience in the pharmaceutical industry, Chris has a strong focus on R&D and strategic business development. Since joining GSK in 2011, Chris has held senior business development roles in transactions, Oncology Business Development, Respiratory Business Development, and Scientific Licensing. Before joining GSK, Chris served in various positions of increasing responsibility in business development and research and development at Pfizer. Chris holds an M.B.A. from the Open University and a BSc in Pharmacology from the University of Southampton.